Montelukast, cysteinyl leukotriene receptor 1 antagonist, inhibits cardiac fibrosis by activating APJ
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Montelukast, cysteinyl leukotriene receptor 1 antagonist, inhibits cardiac fibrosis by activating APJ
Authors
Keywords
Montelukast, APJ receptor, Cardiac fibrosis
Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 923, Issue -, Pages 174892
Publisher
Elsevier BV
Online
2022-03-28
DOI
10.1016/j.ejphar.2022.174892
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Downregulation of ADAM17 Exerts Protective Effects against Cardiac Fibrosis by Regulating Endoplasmic Reticulum Stress and Mitophagy
- (2021) Chang Guan et al. Oxidative Medicine and Cellular Longevity
- Apelin and APJ orchestrate complex tissue-specific control of cardiomyocyte hypertrophy and contractility in the hypertrophy-heart failure transition
- (2018) Victoria Nicole Parikh et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- LncRNA PFL contributes to cardiac fibrosis by acting as a competing endogenous RNA of let-7d
- (2018) Haihai Liang et al. Theranostics
- Mechanisms underlying the protective effect of montelukast in prevention of endometrial hyperplasia in female rats
- (2018) Walaa Yehia Abdelzaher et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Apelin Is a Negative Regulator of Angiotensin II–Mediated Adverse Myocardial Remodeling and DysfunctionNovelty and Significance
- (2017) Zhen-Zhou Zhang et al. HYPERTENSION
- Fibroblast-specific TGF-β–Smad2/3 signaling underlies cardiac fibrosis
- (2017) Hadi Khalil et al. JOURNAL OF CLINICAL INVESTIGATION
- MicroRNA-503 promotes angiotensin II-induced cardiac fibrosis by targeting Apelin-13
- (2016) Yuhong Zhou et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Discovery and Structure–Activity Relationship of a Bioactive Fragment of ELABELA that Modulates Vascular and Cardiac Functions
- (2016) Alexandre Murza et al. JOURNAL OF MEDICINAL CHEMISTRY
- Apelin-13 protects against myocardial infarction-induced myocardial fibrosis
- (2016) XUEMIN ZHANG et al. Molecular Medicine Reports
- NMR structure and dynamics of the agonist dynorphin peptide bound to the human kappa opioid receptor
- (2015) Casey O’Connor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Toddler: An Embryonic Signal That Promotes Cell Movement via Apelin Receptors
- (2014) A. Pauli et al. SCIENCE
- ELABELA: A Hormone Essential for Heart Development Signals via the Apelin Receptor
- (2013) Serene C. Chng et al. DEVELOPMENTAL CELL
- Ligand–receptor interaction platforms and their applications for drug discovery
- (2012) Ye Fang Expert Opinion on Drug Discovery
- Cardioprotective Effect of Apelin-13 on Cardiac Performance and Remodeling in End-Stage Heart Failure
- (2011) Wataru Koguchi et al. CIRCULATION JOURNAL
- Astragaloside IV attenuates myocardial fibrosis by inhibiting TGF-β1 signaling in coxsackievirus B3-induced cardiomyopathy
- (2011) Ping Chen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Integrating structure-based and ligand-based approaches for computational drug design
- (2011) Gregory L Wilson et al. Future Medicinal Chemistry
- Apelin protects against angiotensin II-induced cardiovascular fibrosis and decreases plasminogen activator inhibitor type-1 production
- (2011) Khandaker Siddiquee et al. JOURNAL OF HYPERTENSION
- Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice
- (2010) Chiko Shimbori et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Montelukast inhibits neutrophil pro-inflammatory activity by a cyclic AMP-dependent mechanism
- (2009) Ronald Anderson et al. BRITISH JOURNAL OF PHARMACOLOGY
- Apelin-13 induces ERK1/2 but not p38 MAPK activation through coupling of the human apelin receptor to the Gi2pathway
- (2008) Bo Bai et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Montelukast inhibits tumour necrosis factor-α-mediated interleukin-8 expression through inhibition of nuclear factor-κB p65-associated histone acetyltransferase activity
- (2008) F. Tahan et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Montelukast inhibition of resting and GM-CSF-stimulated eosinophil adhesion to VCAM-1 under flow conditions appears independent of cysLT1R antagonism
- (2008) A. J. Robinson et al. JOURNAL OF LEUKOCYTE BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now